Skip to main content
logo
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
28.77
+0.26 (0.91%)
At close: Mar 4, 2026, 4:00 PM EST
28.77
0.00 (0.00%)
After-hours: Mar 4, 2026, 5:38 PM EST

Mineralys Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
217.6114.0949.387.710.611.41
Short-Term Investments
376.0384.1187.2622.41--
Cash & Short-Term Investments
593.63198.19236.57110.1110.611.41
Cash Growth
125.20%-16.22%114.85%937.60%653.16%-
Other Current Assets
6.177.1612.542.70.510.06
Total Current Assets
599.8205.35249.1112.8111.121.47
Net Property, Plant & Equipment
0.010.05----
Long-Term Investments
--2.48---
Other Long-Term Assets
0.140.50.051.6300.02
Total Assets
599.95205.9251.64114.4411.131.49
Accounts Payable
1.120.480.61.910.760.53
Accrued Expenses
22.414.179.886.164.290.05
Short-Term Debt
-----4.5
Total Current Liabilities
23.5214.6510.488.075.055.08
Total Liabilities
23.5214.6510.488.075.055.08
Common Stock
0.010.010000
Additional Paid-in Capital
1,001493.77365.860.540.090.01
Retained Earnings
-424.94-302.52-124.71-52.81-23.01-3.6
Total Common Shareholders' Equity
576.43191.26241.15-52.27-22.93-3.6
Minority Interest
---158.6429-
Shareholders' Equity
576.43191.26241.15106.386.07-3.6
Total Liabilities & Equity
599.95205.9251.64114.4411.131.49
Total Debt
-00004.5
Net Cash (Debt)
593.63198.19236.57110.1110.61-3.09
Net Cash Growth
199.53%-16.22%114.85%937.60%--
Net Cash Per Share
9.934.086.5421.312.13-
Book Value
576.43191.26241.15-52.27-22.93-3.6
Book Value Per Share
9.643.946.66-10.12-4.60-
Tangible Book Value
576.43191.26241.15-52.27-22.93-3.6
Tangible Book Value Per Share
9.643.946.66-10.12-4.60-
Updated Nov 10, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q